Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCommon EquityCurrent Deferred RevenueCurrent TaxesLiabilities and Shareholders EquityNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zenvia (ZENV) Liabilities and Shareholders Equity (2020 - 2025)

Historic Liabilities and Shareholders Equity for Zenvia (ZENV) over the last 6 years, with Q2 2025 value amounting to $295.4 million.

  • Zenvia's Liabilities and Shareholders Equity fell 1395.51% to $295.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.2 billion, marking a year-over-year decrease of 9968.28%. This contributed to the annual value of $325.4 million for FY2024, which is 588.85% down from last year.
  • According to the latest figures from Q2 2025, Zenvia's Liabilities and Shareholders Equity is $295.4 million, which was down 1395.51% from $298.1 million recorded in Q1 2025.
  • Over the past 5 years, Zenvia's Liabilities and Shareholders Equity peaked at $385.9 billion during Q2 2022, and registered a low of $317546.9 during Q1 2022.
  • In the last 5 years, Zenvia's Liabilities and Shareholders Equity had a median value of $344.3 million in 2021 and averaged $89.4 billion.
  • Within the past 5 years, the most significant YoY rise in Zenvia's Liabilities and Shareholders Equity was 40623706.61% (2022), while the steepest drop was 9999.97% (2022).
  • Quarter analysis of 5 years shows Zenvia's Liabilities and Shareholders Equity stood at $330.6 million in 2021, then rose by 3.74% to $342.9 million in 2022, then rose by 0.81% to $345.7 million in 2023, then fell by 13.22% to $300.0 million in 2024, then decreased by 1.54% to $295.4 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $295.4 million for Q2 2025, versus $298.1 million for Q1 2025 and $300.0 million for Q4 2024.